【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Graft Versus Host Disease (GVHD) Overview 10
Therapeutics Development 11
Pipeline Products for Graft Versus Host Disease (GVHD) – Overview 11
Pipeline Products for Graft Versus Host Disease (GVHD) – Comparative Analysis 12
Graft Versus Host Disease (GVHD) – Therapeutics under Development by Companies 13
Graft Versus Host Disease (GVHD) – Therapeutics under Investigation by Universities/Institutes 18
Graft Versus Host Disease (GVHD) – Pipeline Products Glance 19
Late Stage Products 19
Clinical Stage Products 20
Early Stage Products 21
Unknown Stage Products 22
Graft Versus Host Disease (GVHD) – Products under Development by Companies 23
Graft Versus Host Disease (GVHD) – Products under Investigation by Universities/Institutes 27
Graft Versus Host Disease (GVHD) – Companies Involved in Therapeutics Development 28
AbGenomics International, Inc. 28
Adienne Pharma & Biotech 29
Alder Biopharmaceuticals Inc. 30
Alexion Pharmaceuticals, Inc. 31
Apceth GmbH & Co. KG 32
Athersys, Inc. 33
Bellicum Pharmaceuticals, Inc. 34
Biogen Idec Inc. 35
Dr. Falk Pharma GmbH 36
Enlivex Therapeutics Ltd 37
Escape Therapeutics, Inc. 38
F. Hoffmann-La Roche Ltd. 39
Generon (Shanghai) Corporation Ltd. 40
Idera Pharmaceuticals, Inc. 41
ImmuNext, Inc. 42
Immunomedics, Inc. 43
Jazz Pharmaceuticals plc 44
Kadmon Corporation, LLC 45
Kamada Ltd. 46
Kymab Limited 47
Lycera Corp. 48
Mesoblast Limited 49
Millennium Pharmaceuticals, Inc. 50
MSM Protein Technologies, Inc. 51
Neopharm Ltd. 52
NeoStem, Inc. 53
Novartis AG 54
Omni Bio Pharmaceutical Inc. 55
Pharmacyclics, Inc. 56
Pharmicell Co., Ltd. 57
Pluristem Therapeutics Inc. 58
R-Tech Ueno, Ltd. 59
REGiMMUNE Corporation 60
Rigel Pharmaceuticals, Inc. 61
Sarepta Therapeutics, Inc. 62
Seattle Genetics, Inc. 63
Sigmoid Pharma Limited 64
Soligenix, Inc. 65
Spherium Biomed S.L. 66
Targazyme, Inc. 67
Therapix Biosciences Ltd 68
Tobira Therapeutics, Inc. 69
Xenikos B.V. 70
Graft Versus Host Disease (GVHD) – Therapeutics Assessment 71
Assessment by Monotherapy Products 71
Assessment by Combination Products 72
Assessment by Target 73
Assessment by Mechanism of Action 76
Assessment by Route of Administration 79
Assessment by Molecule Type 81
Drug Profiles 83
AbGn-168H – Drug Profile 83
aldesleukin – Drug Profile 85
Alecmestencel-L – Drug Profile 87
Alpha-1 Antitrypsin – Drug Profile 88
alpha-1 proteinase inhibitor (human) – Drug Profile 89
ALXN-1007 – Drug Profile 91
anti-thymocyte globulin (rabbit) – Drug Profile 92
Antibodies to Antagonize CD40L for Autoimmune Diseases and GVHD – Drug Profile 94
Antisense Oligonucleotide to Inhibit TLRs for Systemic Lupus Erythematosus and Graft Versus Host Disease – Drug Profile 95
ApoCell – Drug Profile 96
beclomethasone dipropionate – Drug Profile 97
begelomab – Drug Profile 99
bortezomib – Drug Profile 100
BPX-501 – Drug Profile 105
brentuximab vedotin – Drug Profile 107
budesonide – Drug Profile 112
Bz-423 – Drug Profile 115
cannabidiol – Drug Profile 116
Cell Therapy for Autoimmune Diseases and GVHD – Drug Profile 117
Cell Therapy for CNS, Respiratory, Immunology and Metabolic Disorders – Drug Profile 119
Cell Therapy for Graft Versus Host Disease – Drug Profile 120
Cell Therapy for Graft Versus Host Disease – Drug Profile 121
Cell Therapy for Graft Versus Host Disease – Drug Profile 122
Cell Therapy for Graft versus Host Disease – Drug Profile 123
Cell Therapy for Graft-Versus Host Disease – Drug Profile 124
Cell Therapy for GVHD – Drug Profile 125
cenicriviroc mesylate – Drug Profile 126
Cerecellgram for Graft Versus Host Disease – Drug Profile 128
clazakizumab – Drug Profile 129
Coversin – Drug Profile 131
cyclosporine IR + cyclosporine CR – Drug Profile 132
defibrotide – Drug Profile 133
Drugs for Acute and Chronic GVHD – Drug Profile 136
Drugs for Graft Versus Host Disease – Drug Profile 137
erismodegib – Drug Profile 138
F-652 – Drug Profile 141
Fc-Alpha-1 Antitrypsin – Drug Profile 142
FcAAT-2 – Drug Profile 143
FcAAT-3 – Drug Profile 144
Ha-7 – Drug Profile 145
ibrutinib – Drug Profile 146
ImmuneSafe – Drug Profile 152
ImmuStem – Drug Profile 153
IMO-8400 – Drug Profile 154
inolimomab – Drug Profile 156
IT-603 – Drug Profile 157
IT-901 – Drug Profile 158
KD-025 – Drug Profile 159
KY-1005 – Drug Profile 161
milatuzumab – Drug Profile 162
Monoclonal Antibody to Inhibit CD3 for Autoimmune Disorders, CNS Disorders, Infectious Diseases, Liver Diseases, Metabolic Disorders and Cardiovascular Diseases – Drug Profile 164
MSM-707 – Drug Profile 166
MultiStem – Drug Profile 167
natalizumab – Drug Profile 170
Oligonucleotide to Inhibit NFAT1 for GVHD – Drug Profile 172
panobinostat – Drug Profile 173
PLX-RAD – Drug Profile 179
Protein to Activate TLR5 for Infectious Disease and GVHD – Drug Profile 182
Recombinant HIV Gp120 Protein for GvHD And Autoimmune Disorders – Drug Profile 183
Recombinant Protein to Inhibit ILT3 for Graft Versus Host Disease – Drug Profile 184
remestemcel-L – Drug Profile 185
RGI-2001 – Drug Profile 188
RO-2959 – Drug Profile 190
Small Molecule for Graft Versus Host Disease, Hemophagocytic Lymphohistiocytosis and Autoimmune Disorders – Drug Profile 191
Small Molecule to Inhibit Protein Kinase C Theta for Autoimmune Disorder – Drug Profile 192
Small Molecules to Activate Telomerase for ALS, GVHD, Ageing and Leukemia – Drug Profile 193
Small Molecules to Inhibit SHIP1 for Oncology and Immunology – Drug Profile 194
SP-12008 – Drug Profile 195
T-Guard – Drug Profile 196
TZ-101 – Drug Profile 198
Graft Versus Host Disease (GVHD) – Recent Pipeline Updates 200
Graft Versus Host Disease (GVHD) – Dormant Projects 283
Graft Versus Host Disease (GVHD) – Discontinued Products 287
Graft Versus Host Disease (GVHD) – Product Development Milestones 288
Featured News & Press Releases 288
Appendix 296
Methodology 296
Coverage 296
Secondary Research 296
Primary Research 296
Expert Panel Validation 296
Contact Us 296
Disclaimer 297
【レポート販売概要】
■ タイトル：移植片対宿主病(Graft Versus Host Disease (GVHD))：治療薬開発パイプライン動向（2015年上半期版）■ 英文：Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015
■ 発行日：2015年3月19日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6249IDB
■ 調査対象地域：グローバル
- オーディオコーデックの世界市場予測（～2022）The audio codec market was valued at USD 5.49 Billion in 2015 and is expected to reach USD 7.44 Billion by 2022, at a CAGR of 4.3% between 2016 and 2022. The growth of the market is driven by the factors such as increasing Internet penetration and data traffic and growing mobile phone subscription. In almost all the regions, the consumer’s pattern is changing with the emergence of connected life i …
- ヘッドマウントディスプレイ（HMD/スマートグラス）の世界市場About Head Mounted Displays HMD (head mounted displays) comprise small displays with lenses and semi-transparent mirrors embedded in them, which makes them look like a pair of eyeglasses. They are also sometimes referred to as “smart glasses.” A head-mounted display consists of an image source, collimating optics, and a mechanism to mount the device on the head. The device is wearable, and project …
- 世界のアクリル接着剤市場2015The Global Acrylic Adhesives Industry Report 2015 is a professional and in-depth study on the current state of the Acrylic Adhesives industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Acrylic Adhesives market analysis is provided for the international markets including development trends, competitive …
- EGP-437 (Dry Eye Syndrome)：市場予測と分析（～2022）EGP-437 (Dry Eye Syndrome) - Forecast and Market Analysis to 2022 Summary Dry eye syndrome (DES), or keratoconjunctivitis sicca, is a multifactorial disease of the eye caused by dryness, decreased tear production, or increased tear film evaporation. DES, which is often referred to simply as dry eye, is the most prevalent form of ocular discomfort and irritation. The most common symptoms of DES are …
- ハイブリッドパソコンの世界市場2015-2019About hybrid PC A hybrid PC is a 2-in-1 device that functions as a tablet as well as a laptop. Hybrid PC has a detachable screen. Based on the screen size, a hybrid PC is classified into three: 10-12 inches, 12-14 inches, and above 14 inches. Technavio's analysts forecast the global Hybrid PC market to grow at a CAGR of 21.5% in terms of revenue over the period 2014-2019. [Covered in this report] …
- モバイルアプリケーションの世界市場：マーケットプレイス別（Apple iOSストア、Google Playストア、その他）、アプリカテゴリ別（ゲーム、エンターテイメント、音楽、健康、フィットネス）Mobile application refers to an application software that is designed to operate on a mobile device such as smartphones, tablets, and laptops. Mobile apps function similar to the programs installed on PCs. These apps are popular owing to their ease of use and quick accessibility. The apps for smartphones or mobile devices are available on some of the popular marketplaces such as, Apple App Store, …
- 多発性硬化症：企業と競争環境PharmaPoint: Multiple Sclerosis - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Multiple Sclerosis - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Multiple Sclerosis Market. The report identifies and analyses the key companies shaping and driving the gl …
- BYODセキュリティソリューションの世界市場：モバイルデバイス管理（MDM）、モバイルアプリケーション管理（MAM）About BYOD Security Enterprise mobility refers to accessing of corporate data by the employees using their personal devices. Enterprise mobility solutions serve the purpose of keeping the remotely working employees of an organization connected with the company and its data. The solution helps capture, manage, store, and transfer of corporate data through cloud-based services. An organization adopt …
- 鉄道車両の世界市場：機関車、高速輸送車両、旅客車、貨車The demand for rolling stock depends on economic development of the country and the government support to develop the country’s infrastructure. The rolling stock market is governed by urbanization following population growth and economic development in emerging nations. The global economic meltdown from 2008–2013 has slowed down growth. However, the long-term outlook of the rail transportation ind …
- ポリテトラフルオロエチレン（PTFE）の世界市場2015-2019About PTFE PTFE is made of raw materials such as hydrochloric acid, fluorspar, and chloroform. It is considered to be a versatile engineered plastic manufactured from TFE. PTFE is semi-crystalline plastic that do not absorb ultraviolet electromagnetic radiation and possess excellent dialectic properties and chemical resistance. These unique characteristics make PTFE most valued plastic for applica …
- ヨーロッパのCEE高炉スラグ市場Statistics of the Central and Eastern Europe blast furnace slag market with detailed classifications, in terms of value and volume have been provided in this report. This market study provides a detailed qualitative and quantitative analysis of the Central and Eastern Europe blast furnace slag market. The report provides a comprehensive review of the major market drivers and restraints. The market …
- Canadian Natural Resources Limited：石油・ガスバリューチェーン分析レポート2013Canadian Natural Resources Limited Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Canadian Natural Resources Limited" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Canadian Natural Resources Limited”. The report provides key information relating to oil and gas assets of the company along with its operatio …
- ガスコンプレッサーの世界市場About Gas CompressorsA gas compressor helps in reducing the volume of gas to increase its pressure. The phenomenon follows Boyle's law. An air compressor is a distinct type of gas compressor. Technavio’s analysts forecast the global gas compressors market to grow at a CAGR of 4.50% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the growth prospects …
- 世界のIoNT（Internet of Nano Things）市場：通信種類別/ナノデバイス別/産業別分析The interconnectivity of nanoscale devices with deployed Internet networks has become the centre of all business activities; this is described as Internet of Nano Things (IoNT). It is the essence of smart connectivity of devices implemented for communication. It will help in seamless transfer of data among the devices with the help of a given spectrum. The internetwork of devices will change over …
- Apco Oil and Gas International Inc.：石油・ガスの開発・生産動向及びコスト分析– Q1, 2013Apco Oil and Gas International Inc. Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013 Summary Apco Oil and Gas International Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The r …
